Development, validation and greenness assessment of stability indicating RP-HPLC method for simultaneous quantification of dapagliflozin and metoprolol succinate in synthetic mixture
Abstract
A novel, rapid, accurate, precise and simple stability indicating RP-HPLC method has been proposed and validated for the concurrent quantitation of Dapagliflozin and Metoprolol succinate in laboratory prepared mixture. The greenness assessment of the proposed approach was accomplished utilizing GAPI and AGREE tools. The final chromatographic run was performed utilizing Methanol: 20mM Potassium Dihydrogen Phosphate: (70:30) as eluent, injected at 25°C at a rate of 1.5 mL/min. Cosmosil-MS-5 C18 column (250 mm × 4.6 mm, 5 μm) was utilised and estimation was done using 223 nm. The APIs were exposed to stress environments (oxidation, acidic and basic hydrolysis, photolysis and thermal stimuli) and stressed samples were analysed under same chromatographic condition. Dapagliflozin and metoprolol succinate had retention times of 11.6 and 2.6 minutes, correspondingly. It was demonstrated having linearity within 10-30 µg/mL for Dapagliflozin and 50–150 µg/mL for Metoprolol succinate. The % accuracy for Dapagliflozin were in the range of 99.01 - 100.56 %, while for Metoprolol succinate it was within 99.32 - 101.41 % at three levels. The outcomes for precision study were within the limits. For Dapagliflozin, the LOD and LOQ were 0.49 µg/mL and 0.59 µg/mL correspondingly and for Metoprolol succinate, values were 1.48 µg/mL and 1.79 µg/mL correspondingly. The approach is effectively suggested for stability-indicating research as well as for routine estimation of Dapagliflozin and Metoprolol succinate in bulk and laboratory prepared mixture. Furthermore, AGREE and GAPI outcomes confirmed the developed approach’s eco–friendliness and greenness.
Keywords:
Dapagliflozin, Metoprolol Succinate, RP-HPLC Method, Stability Studies, AGREE, GAPIDOI
https://doi.org/10.25004/IJPSDR.2024.160607References
Jenča D, Melenovský V, Stehlik J, Staněk V, Kettner J, Kautzner J, Adámková V, Wohlfahrt P. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Failure 2020; 8(1):222–37. https://doi.org/10.1002/ehf2.13144.
World Health Organization: WHO Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).Accessed 9 September 2024.
Sabbagh B, Lokesh BVS, Akouwah GA. Validated RP-HPLC and UV-spectroscopy methods for the estimation of Dapagliflozin in bulk and in tablets. Indian drugs 2017; 54(03):44–51. https://doi.org/10.53879/id.54.03.10721
Soni S, Ram V, Verma D, Verma A. Analytical method development and validation of metoprolol succinate by high performance liquid Chromatography and Ultraviolet spectroscopy technique. Res J Pharm Technol. 2021; 14(2):931–937. https://doi.org/10.5958/0974-360x.2021.00166.9
CT approvals. https://cdsco.gov.in/opencms/opencms/en/Approval_new/CT-Approvals/.Accessed 3 August 2024.
Swaroop G. Post-myocardial infarction Heart Failure: A review on Management of drug therapies. Curēus. 2022; 14(6):e25745. https://doi.org/10.7759/cureus.25745
Tobiszewski M. Metrics for green analytical chemistry. Anal. Methods. 2016; 8(15):2993–2999. https://doi.org/10.1039/c6ay00478d
Alsante K, Ando A, Brown R, Ensing J, Hatajik T, Kong W, Tsuda Y. The role of degradant profiling in active pharmaceutical ingredients and drug products. Adv Drug Deliv Rev. 2007; 59(1):29–37. https://doi.org/10.1016/j.addr.2006.10.006
Blessy M, Patel RD, Prajapati PN, Agrawal YK. Development of forced degradation and stability indicating studies of drugs—A review. J Pharm Anal. 2014; 4(3):159–165. https://doi.org/10.1016/j.jpha.2013.09.003
Sanagapati M, Dhanalakshmi K, Nagarjuna G, Sreenivasa S. Method Development and Validation of Dapagliflozin in API by RP-HPLC and UV Spectroscopy. International Journal of Pharmaceutical Sciences and Drug Research 2014; 6:250-52.
Sarkar S, Patel VP. Method Development and Validation of Dapagliflozin Drug in Bulk and Tablet Dosage form by RP-HPLC. Int. J. Pharm. Res. Health Sci. 2017; 5(4):1755-1759. https://doi.org/10.21276/ijprhs.2017.04.07.
Pal N, Mahtab T, Reddy PP, Rao AS. A new HPLC method development and validation for the determination of Dapagliflozin in tablet dosage form. World J. Pharm. Res. 2019; 8(9):1156-1165. https://doi.org/10.20959/wjpr20199-15503.
Debata J, Kumar S, Jha SK, Khan A. A New RP-HPLC method development and validation of Dapagliflozin in bulk and tablet dosage form. Int. J. Drug Dev. Res. 2017; 9(2):48-51.
Chaudhari U, Sahu JK, Dande PR. Analytical Method Development, Validation and Forced Degradation Study of Dapagliflozin by RP-HPLC. Drug Metab. Bioanal. Lett. 2023; 16(2): 140-152. https://doi.org/10.2174/2949681016666230823091112.
Vaghela YV, Patani P, Patel D. Development and Validation of stability indicating estimation method of Dapagliflozin in its tablet dosage form. Int. J. Res. Anal. Rev. 2019; 6(2):206-13.
Sharan LM, Madhuri D. DOE Approach: A Validated RP-HPLC Method for the Determination of Dapagliflozin. J. Surv. Fish. Sci. 2023; 10(1):4019-28. https://doi.org/10.53555/sfs.v10i1.1862.
Verma MV, Patel CJ, Patel MM. Development and Stability Indicating HPLC method for Dapagliflozin in API and Pharmaceutical dosage form. Int. J. App. Pharm. 2017; 9(5):33-41. http://dx.doi.org/10.22159/ijap.2017v9i5.19185.
Caroline GA, Prabha T, Sivakumar T. Development and Validation of High Performance Liquid Chromatographic Method for determination of Dapagliflozin and its impurities in tablet dosage form. Asian J. Pharm. Clin. Res. 2019; 12(3):447-53. http://dx.doi.org/10.22159/ajpcr.2019.v12i3.30853.
Ameeduzzafar, El-Bagory I, Alruwaili NK, Imam SS, Alomar FA, Elkomy MH, et al. Quality by design (QbD) based development and validation of bioanalytical RP-HPLC method for dapagliflozin: forced degradation and preclinical pharmacokinetic study. J. Liq. Chromatogr. Relat. Technol. 2020; 43(1-2):53-65. https://doi.org/10.1080/10826076.2019.1667820.
Agarwal B, Gandhi S. Potential of RP-HPLC-DAD-MS for the Qualitative and Quantitative Analysis of Dapagliflozin in Tablets and Degradants. Indian Drugs. 2018; 55 (11):45-50. https://doi.org/10.53879/id.55.11.11493.
Manoharan G, Ismaiel AM, Ahmed ZM. Stability-indicating RP-HPLC method development for simultaneous determination and estimation of Dapagliflozin in raw and tablet formulation. Chem. Res. J. 2018; 3(2):159-64.
Jeyabaskaran M, Rambabu C, Dhanalakshmi B. RP-HPLC method Development and Validation of Dapagliflozin in bulk and tablet formulation. International Journal of Pharmacy and Analytical Research. 2013; 2:221-26.
Sura S, Modalavalasa RR, Kothapalli CB. Validation of a newly developed stability indicating RP-Liquid Chromatographic Method for the Quantitative Determination of Dapagliflozin. Der Pharma. Chemica. 2018; 10(1): 93-102.
Shakirbasha S, Sravanthi P. Development and validation of Dapagliflozin by reversed-phase high-performance liquid chromatography method and it’s forced degradation studies. Asian J. Pharm. Clin. Res. 2017; 10(11):101-05. https://doi.org/10.22159/ajpcr.2017.v10i11.19705.
Sunkara B, Tummalapalli Naga Venkata GK. Development of novel gradient RP-HPLC method for separation of Dapagliflozin and its process-related impurities: insight into stability profile and degradation pathway, identification of degradants using LCMS. Futur. J. Pharm. Sci. 2023; 9:107. https://doi.org/10.1186/s43094-023-00556-3.
Chandana M, Rao MP, Ramya B, Sagar DV, Marsis DT, Gnana R, et al. Quantification of Metoprolol Succinate in bulk and tablet formulation by HPLC: Method development and validation. European Journal of Pharmacy and Research. 2016; 11(4):31-40.
Kalisetty S, Reddy TS, Reddy AM, Rao DV, Raju MS, Vyas K. Ultra performance liquid chromatographic method development and validation for the quantification of impurities and degradation products in the Metoprolol Succinate ER tablets. Int. J. Pharma. Bio. Sci. 2012; 2(4):247-55.
Phadke R, Gosar A. A rapid and sensitive validated high performance liquid chromatography method for determination of related substances in Metoprolol Succinate (API). Eur. J. Pharm. Med. Res. 2018; 5:333-42.
Soni S, Ram V, Verma D, Verma A. Analytical Method Development and Validation of Metoprolol Succinate by High Performance Liquid Chromatography and Ultraviolet Spectroscopy Technique. Res. J. Pharm. Technol. 2021; 14(2):931-37. http://dx.doi.org/ 10.5958/0974-360X.2021.00166.9.
Syed SM, Marathe RP, Mahaparale PR. Development and Validation of UV Spectrophotometric and RP-HPLC Method for Metoprolol Succinate. International Research Journal of Pharmacy. 2019; 10(11):24-8. http://dx.doi.org/10.7897/2230-8407.1011315.
Guguloth R, Madhukar A, Umadevi G, Lalitha T, Ravinder A. Analytical method development and validation for the determination of Metoprolol Succinate in tablet dosage form by RP-HPLC techniques. J. Sci. Res. Pharm. 2016; 5(6):74-7.
Bhandari PG, Mahida RJ. Reverse Phase-HPLC Method Development and Validation for the Simultaneous Estimation of Dapagliflozin Propanediol Monohydrate and Metoprolol Succinate. J Emerg Technol Innov Res. 2024; 11(6):g738-g52.
The International Conference on Harmonization (ICH), Validation of Analytical Procedure: Text and Methodology, Q2 (R1). Geneva, Switzerland (2005).
ICH Harmonised Tripartite guidelines: Stability testing of new drug substances and products, Q1A (R2). Geneva, Switzerland (2003).
Płotka-Wasylka J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta 2018; 181:204-09. https://doi.org/10.1016/j.talanta.2018.01.013.
Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE—analytical GREEnness metric approach and software. Anal. Chem. 2020; 92(14):10076-82. https:// doi.org/10.1021/acs.analchem.0c01887.
Published
PDF Downloads: 97
How to Cite
Issue
Section
Copyright (c) 2024 Sapna Rathod, Ayushi Shah, Nisarg Patel
This work is licensed under a Creative Commons Attribution 4.0 International License.